DELCATH SYSTEMS, INC.

Develops targeted chemotherapy delivery systems for treating primary and metastatic liver cancers.

DCTH | NDAQ

Overview

Corporate Details

ISIN(s):: US24661P8077
LEI:
Country:: United States of America
Address:: 566 QUEENSBURY AVENUE, 12804 QUEENSBURY
Website:: https://delcath.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Delcath Systems, Inc. is a commercial-stage, interventional oncology company focused on treating primary and metastatic liver cancers. The company develops and commercializes specialty pharmaceutical and medical device products based on its proprietary percutaneous hepatic perfusion (PHP) technology. This minimally-invasive procedure is designed to deliver high-dose chemotherapy directly to the liver while controlling systemic side effects. Its flagship products are the HEPZATO KIT™, recently FDA-approved in the U.S. for treating metastatic uveal melanoma, and the CHEMOSAT® Hepatic Delivery System, a medical device available in Europe. Delcath aims to provide targeted, minimally-invasive treatment options for patients with liver-dominant cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Precision System Science Co., Ltd. Automated systems for lab diagnostics, genetic testing, and DNA/RNA extraction.	Japan	7707
Primotec Group Ltd. Provider of digital and classic dental technology solutions for dental laboratories.	Israel	PRMG
Prim S.A. Designs & manufactures orthopedic and hospital supplies for mobility, rehab, and physiotherapy.	Spain	PRM
PROCEPT BioRobotics Corp Surgical robotics company providing AI-guided waterjet therapy for BPH treatment in urology.	United States of America	PRCT
PRO DEX INC Manufactures powered surgical, dental, and rotary drive systems for medical device OEMs.	United States of America	PDEX
Profusa, Inc. Develops injectable biosensors for continuous, long-term monitoring of body chemistries.	United States of America	PFSA
Promimic AB Nano-thin surface coatings for orthopedic & dental implants that accelerate bone healing.	Sweden	PRO
ProstaLund AB Develops minimally invasive heat treatments and devices for BPH for global healthcare providers.	Sweden	PLUN
Prostatype Genomics AB Provides a genetic test to assess prostate cancer aggressiveness and guide treatment choices.	Sweden	PROGEN
Pulmonx Corp Offers minimally invasive valves to treat severe emphysema/COPD and improve breathing.	United States of America	LUNG